Filings obtained by unquote” confirm Abingworth has secured $115m of commitments from institutional investors for its latest Bioventures fund.
Abingworth Bioventures (ABV) VII will be the GP's 11th venture-focused fund, and is understood to be targeting $400m. Abingworth has so far declined to comment. The GP's 2012-vintage Abingworth Bioventures...
Venture capital firms originally invested in the company in 2011 and 2014 respectively
Fund manager Quaestus exits its stake in the Croatian business after an eight-year holding period
Proposed deal for the aluminium profiles manufacturer comes just two years after Advent's acquisition
Deal marks first investment by small-cap buyout fund Crescendo, which held a €42m first close this year